Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Masumi Iketani"'
Autor:
Toshiyuki Aokage, Masumi Iketani, Mizuki Seya, Ying Meng, Kohei Ageta, Hiromichi Naito, Atsunori Nakao, Ikuroh Ohsawa
Publikováno v:
Experimental Gerontology, Vol 180, Iss , Pp 112270- (2023)
Introduction: With the global population aging, there is an increased prevalence of sepsis among the elderly, a demographic particularly susceptible to inflammation. This study aimed to evaluate the therapeutic potential of hydrogen gas, known for it
Externí odkaz:
https://doaj.org/article/0b8425f69a304035a3254a82c404e65f
Autor:
Toshiyuki Aokage, Mizuki Seya, Takahiro Hirayama, Tsuyoshi Nojima, Masumi Iketani, Michiko Ishikawa, Yasuhiro Terasaki, Akihiko Taniguchi, Nobuaki Miyahara, Atsunori Nakao, Ikuroh Ohsawa, Hiromichi Naito
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-15 (2021)
Abstract Background Acute respiratory distress syndrome, which is caused by acute lung injury, is a destructive respiratory disorder caused by a systemic inflammatory response. Persistent inflammation results in irreversible alveolar fibrosis. Becaus
Externí odkaz:
https://doaj.org/article/58f7a2d72e1948ee941a0ae606f85866
Publikováno v:
Medical gas research. 13(3)
Molecular hydrogen (H
Publikováno v:
Medical Gas Research. 13:133
Publikováno v:
Experimental Gerontology. 165:111866
Mitochondria are dysfunctional in post-senescent cells. Therefore, age-dependent impairment of mitochondrial energy production accompanied by excessive mitochondrial reactive oxygen species (ROS) is proposed to be a key driver of cellular senescence,
Autor:
Toshiyuki Aokage, Mizuki Seya, Takahiro Hirayama, Tsuyoshi Nojima, Masumi Iketani, Michiko Ishikawa, Yasuhiro Terasaki, Akihiko Taniguchi, Nobuaki Miyahara, Atsunori Nakao, Ikuroh Ohsawa, Hiromichi Naito
Background Acute respiratory distress syndrome, which is caused by acute lung injury, is a destructive respiratory disorder caused by a systemic inflammatory response. Persistent inflammation results in irreversible alveolar fibrosis due to excessive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bd515e1ba68b042f7012da3e7627c62
https://doi.org/10.21203/rs.3.rs-504666/v1
https://doi.org/10.21203/rs.3.rs-504666/v1
Autor:
Hiromichi Naito, Michiko Ishikawa, Tsuyoshi Nojima, Toshiyuki Aokage, Yasuhiro Terasaki, Akihiko Taniguchi, Masumi Iketani, Atsunori Nakao, Mizuki Seya, Nobuaki Miyahara, Takahiro Hirayama, Ikuroh Ohsawa
Publikováno v:
BMC Pulmonary Medicine
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-15 (2021)
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-15 (2021)
Background Acute respiratory distress syndrome, which is caused by acute lung injury, is a destructive respiratory disorder caused by a systemic inflammatory response. Persistent inflammation results in irreversible alveolar fibrosis. Because hydroge
Autor:
Masumi Iketani, Ikuroh Ohsawa, Jumi Ohshiro, Hideo Kawaguchi, Takuya Urushibara, Mayumi Takahashi, Tomio Arai
Publikováno v:
Shock. 48:85-93
Despite significant advances in antibiotic therapy and intensive care, sepsis remains the most common cause of death in intensive care units. We previously reported that molecular hydrogen (H2) acts as a therapeutic and preventive antioxidant. Here,
Autor:
Hiroshi Takahashi, Masumi Iketani, Kanako Sekimoto, Ritsuko Ohtani-Kaneko, Ikuroh Ohsawa, Mayumi Takahashi, Iwao Sakane, Hideo Kawaguchi, Tsutomu Igarashi, Masaki Komatsu
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-11 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-11 (2018)
The main cause of arteriosclerosis is atherosclerosis in the aorta. Atherosclerosis is recognized as a chronic inflammatory condition that begins with the dysfunction or activation of arterial endothelium. Low-density lipoprotein (LDL) and especially
Autor:
Seisuke Hattori, Yasuhiro Terasaki, Ikuroh Ohsawa, Masumi Iketani, Suzuki Tetsuya, Yusuke Kajimoto, Kozue Tonaki, Naomi Kuwahara, Mika Terasaki, Akira Shimizu, Makoto Hamanoue, Mayumi Takahashi, Hideo Kawaguchi, Jumi Ohsiro
Publikováno v:
Laboratory investigation; a journal of technical methods and pathology. 99(6)
Although inhibition of epidermal growth factor receptor (EGFR)-mediated cell signaling by the EGFR tyrosine kinase inhibitor gefitinib is highly effective against advanced non-small cell lung cancer, this drug might promote severe acute interstitial